Ganesh V Halade Selected Research

Safflower Oil

1/2022	Metabolic transformation of fat in obesity determines the inflammation resolving capacity of splenocardiac and cardiorenal networks in heart failure.
1/2019	Obesogenic diet in aging mice disrupts gut microbe composition and alters neutrophil:lymphocyte ratio, leading to inflamed milieu in acute heart failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ganesh V Halade Research Topics

Disease

36	Inflammation (Inflammations) 05/2022 - 06/2009
22	Myocardial Infarction 01/2022 - 01/2012
16	Heart Failure 05/2022 - 04/2011
11	Infarction (Infarctions) 07/2021 - 02/2013
8	Obesity 01/2022 - 12/2010
6	Fibrosis (Cirrhosis) 01/2022 - 11/2014
5	Left Ventricular Dysfunction 01/2019 - 02/2013
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 08/2012
4	Body Weight (Weight, Body) 10/2019 - 04/2010
4	Hypertrophy 12/2017 - 10/2009
3	Neoplasms (Cancer) 05/2022 - 11/2018
3	Bone Resorption 01/2021 - 01/2011
3	Necrosis 01/2019 - 01/2018
3	Cicatrix (Scar) 08/2015 - 12/2012
3	Insulin Resistance 05/2015 - 10/2009
2	Cardiotoxicity 10/2019 - 08/2012
2	Cardio-Renal Syndrome 02/2019 - 01/2018
2	Ventricular Remodeling 04/2016 - 02/2016
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2015 - 08/2012
2	Kidney Diseases (Kidney Disease) 06/2013 - 05/2010
2	Glomerulonephritis 06/2013 - 05/2010
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 06/2013 - 05/2010
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Heart Diseases (Heart Disease) 01/2022
1	Hypersplenism (Anemia, Splenic) 01/2022
1	Atherosclerosis 01/2022
1	Ischemic Stroke 07/2021
1	Metabolic Bone Diseases (Osteopenia) 01/2021
1	Ischemia 01/2021
1	Convalescence 11/2020
1	Lymphoid Leukemia 11/2020
1	Hyperinsulinism (Hyperinsulinemia) 01/2020
1	Hyperglycemia 01/2020
1	Coronary Disease (Coronary Heart Disease) 01/2020
1	Cardiomyopathies (Cardiomyopathy) 01/2020

Drug/Important Bio-Agent (IBA)

8	EnzymesIBA 07/2021 - 02/2015
7	LipidsIBA 05/2022 - 01/2014
7	Matrix Metalloproteinases (MMPs)IBA 04/2016 - 02/2013
6	AcidsIBA 01/2022 - 07/2017
6	CollagenIBA 11/2020 - 02/2013
6	CytokinesIBA 12/2018 - 01/2012
5	Lipoxygenase (Lipoxygenase-1)IBA 01/2022 - 01/2014
5	Fish OilsIBA 01/2021 - 05/2010
5	Pharmaceutical PreparationsIBA 11/2020 - 12/2010
4	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 07/2021 - 07/2017
4	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2021 - 05/2010
3	LipoxygenasesIBA 01/2022 - 01/2020
3	CreatinineIBA 01/2022 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2013
3	FatsIBA 01/2022 - 01/2012
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2016
3	resolvin D1IBA 01/2020 - 07/2015
3	ChemokinesIBA 01/2019 - 01/2018
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 08/2015 - 11/2012
3	Glucose (Dextrose)FDA LinkGeneric 05/2015 - 10/2009
3	Corn Oil (Oil, Corn)IBA 04/2011 - 12/2010
2	Sirolimus (Rapamycin)FDA Link 01/2022 - 01/2014
2	Docosahexaenoic AcidsIBA 01/2022 - 05/2010
2	Safflower Oil FDA Link 01/2022 - 01/2019
2	Peptides (Polypeptides)IBA 01/2021 - 02/2016
2	Insulin (Novolin)FDA Link 01/2021 - 04/2011
2	Rosiglitazone (Avandia)FDA Link 01/2021 - 04/2011
2	LipoxinsIBA 01/2020 - 01/2019
2	lipoxin A4IBA 01/2020 - 01/2017
2	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2020 - 01/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2019 - 11/2018
2	carprofen FDA Link 02/2019 - 12/2018
2	Messenger RNA (mRNA)IBA 01/2019 - 02/2013
2	AntioxidantsIBA 01/2019 - 04/2016
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2018 - 07/2017
2	Glycoproteins (Glycoprotein)IBA 02/2016 - 08/2014
2	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 08/2015 - 02/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2015 - 01/2014
2	Cathepsin KIBA 05/2011 - 01/2011
2	Conjugated Linoleic AcidsIBA 04/2010 - 10/2009
1	MacrolidesIBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	FluorocarbonsIBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	HDL CholesterolIBA 01/2022
1	LDL CholesterolIBA 01/2022
1	ProstaglandinsIBA 01/2022
1	ThromboxanesIBA 01/2022
1	Prostaglandin D2IBA 01/2022
1	Matrix Metalloproteinase 3 (Stromelysin 1)IBA 01/2022
1	EndotoxinsIBA 07/2021
1	Kdo2-lipid AIBA 07/2021
1	Lipoxygenase InhibitorsIBA 07/2021
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2021
1	ponatinibIBA 11/2020
1	Ampicillin (Omnipen)FDA LinkGeneric 11/2020
1	Troponin IIBA 11/2020
1	EstersIBA 01/2020
1	5S,12R,18R- trihydroxy- 6Z,8E,10E,14Z,16E- eicosapentaenoic acidIBA 01/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020

Therapy/Procedure

5	Therapeutics 05/2022 - 08/2012
5	Ligation 07/2021 - 01/2018